Carregant...

Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases

Rhenium-188-HEDP ((188)Re-HEDP) is a new and attractive radiopharmaceutical for the treatment of metastatic bone pain. As a product of (188)W/(188)Re generator, it is convenient for clinical therapeutic use with a short physical half-life of 16.9 h and a maximal β-energy of 2.1 MeV. We investigated...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Liepe, K, Kropp, J, Runge, R, Kotzerke, J
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2003
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2376909/
https://ncbi.nlm.nih.gov/pubmed/12915868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601158
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!